Image (Image 01)
Diltiazem Hydrochloride Capsule, Extended Release
Product Images NDC 71335-3091
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Diltiazem Hydrochloride (NDC 71335-3091). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image (Image 02)
This is a comparison of adverse reactions between Diltiazem hydrochloride extended-release capsules and a placebo in placebo-controlled angina and hypertension trials. Common reactions include headache, dizziness, bradycardia, AV Block, Edema, and Asthenia. The data shows the percentage of occurrence for each reaction in the two groups.*
Label (Lbl713353091)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
